重症监护病房脓毒症相关急性肾损伤:发病率、患者特征、时机、轨迹、治疗及相关结局——一项多中心观察性研究
该回顾性队列研究基于ADQI共识定义(联合Sepsis-3与KDIGO AKI标准),在2015至2021年12个ICU的84,528例入院患者中描述SA-AKI的流行病学。13,451例符合SA-AKI标准,2021年发病率峰值达18%。患者多从家中经急诊科(ED)入院,诊断中位时间为入ICU后1天(IQR 1-1);诊断时54%为1期AKI,其中65%仅因低尿量标准诊断。仅低尿量诊断者较肌酐单独或尿量联合肌酐诊断者RRT需求更低(2.8% vs 18% vs 50%;p < 0.001),且住院死亡率更低(OR 0.34,95%CI 0.32-0.36)。SA-AKI住院死亡率为18%,与死亡风险独立相关。
要点
- 12个ICU 2015至2021年84,528例入院中13,451例符合ADQI定义的SA-AKI,2021年发病率峰值18%。
- SA-AKI诊断中位时间为入ICU后1天(IQR 1-1),患者多从家中经急诊科(ED)入院。
- 诊断时54%为1期AKI,65%仅因低尿量标准诊断;仅低尿量诊断者RRT需求2.8%,低于肌酐单独诊断18%及尿量联合肌酐诊断50%(p < 0.001)。
- 仅低尿量诊断较肌酐单独或联合诊断的死亡OR为0.34(95%CI 0.32-0.36)。
- SA-AKI住院死亡率18%,SA-AKI与死亡风险独立相关。
适用人群与场景
- 2015至2021年12个ICU的84,528例入院患者,依据ADQI共识定义(联合Sepsis-3与KDIGO AKI标准)诊断SA-AKI。
- SA-AKI患者多从家中经急诊科(ED)入院。
诊断标准与关键阈值
- SA-AKI诊断采用ADQI共识定义,联合Sepsis-3与KDIGO AKI标准。
研究设计与关键结果
- 研究类型:回顾性队列研究,12个ICU,2015至2021年,84,528例入院。
- 13,451例符合SA-AKI标准,发病率2021年峰值18%;诊断中位时间入ICU后1天(IQR 1-1)。
- 诊断时54%为1期AKI,65%仅因低尿量标准诊断。
- 仅低尿量诊断者RRT需求2.8%,肌酐单独诊断18%,尿量联合肌酐诊断50%(p < 0.001),各AKI分期一致。
- SA-AKI住院死亡率18%;仅低尿量诊断较肌酐单独或联合诊断的死亡OR为0.34(95%CI 0.32-0.36)。
证据类型、等级与局限
- 证据类型:多中心回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,多数SA-AKI为1期且多因低尿量诊断,其风险远低于其他标准诊断的SA-AKI。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: The Acute Disease Quality Initiative (ADQI) Workgroup recently released a consensus definition of sepsis-associated acute kidney injury (SA-AKI), combining Sepsis-3 and Kidney Disease Improving Global Outcomes (KDIGO) AKI criteria. This study aims to describe the epidemiology of SA-AKI.
METHODS: This is a retrospective cohort study carried out in 12 intensive care units (ICUs) from 2015 to 2021. We studied the incidence, patient characteristics, timing, trajectory, treatment, and associated outcomes of SA-AKI based on the ADQI definition.
RESULTS: Out of 84,528 admissions, 13,451 met the SA-AKI criteria with its incidence peaking at 18% in 2021. SA-AKI patients were typically admitted from home via the emergency department (ED) with a median time to SA-AKI diagnosis of 1 day (interquartile range (IQR) 1-1) from ICU admission. At diagnosis, most SA-AKI patients (54%) had a stage 1 AKI, mostly due to the low urinary output (UO) criterion only (65%). Compared to diagnosis by creatinine alone, or by both UO and creatinine criteria, patients diagnosed by UO alone had lower renal replacement therapy (RRT) requirements (2.8% vs 18% vs 50%; p < 0.001), which was consistent across all stages of AKI. SA-AKI hospital mortality was 18% and SA-AKI was independently associated with increased mortality. In SA-AKI, diagnosis by low UO only, compared to creatinine alone or to both UO and creatinine criteria, carried an odds ratio of 0.34 (95% confidence interval (CI) 0.32-0.36) for mortality.
CONCLUSION: SA-AKI occurs in 1 in 6 ICU patients, is diagnosed on day 1 and carries significant morbidity and mortality risk with patients mostly admitted from home via the ED. However, most SA-AKI is stage 1 and mostly due to low UO, which carries much lower risk than diagnosis by other criteria.
参考来源
- White KC, Serpa-Neto A, Hurford R, et al. Sepsis-associated acute kidney injury in the intensive care unit: incidence, patient characteristics, timing, trajectory, treatment, and associated outcomes. A multicenter, observational study. Intensive Care Med. 2023. PMID: 37432520. doi:10.1007/s00134-023-07138-0
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。